CoChat

Insulin Sensitivity in Cystic Fibrosis

Moran, Aantoinette, Pyzdrowski, Kathryn L, Weinreb, Jane, Kahn, Barbara B, Smith, Stephen A, Adams, Karwyn S, Seaquist, Elizabeth R · 1994 · Diabetes
Cited by 144

The DOI matches its Crossref record.

Abstract

Cystic fibrosis (CF) patients demonstrate a spectrum of pancreatic β-cell abnormalities. Those with no exocrine insufficiency (NEXO) have normal insulin secretion. Exocrine-insufficient CF patients with overt diabetes (EXO-IT) have impaired insulin secretion and fasting hyperglycemia. Exocrine-insufficient patients without diabetes (EXO) have impaired insulin secretion but maintain normoglycemia. We postulated that EXO individuals compensate for insulin deficiency by increasing insulin sensitivity and investigated glucose utilization in CF. To examine hepatic and peripheral insulin sensitivity, euglycemic-hyperinsulinemic clamp studies were performed by using the hot GINF isotope dilution technique. Insulin was sequentially infused at 0.25, 1.0, and 10.0 mU · kg−1 · min−1. Glucose-mediated glucose uptake (GMGU) was assessed on another day with hyperglycemic clamp studies, during which insulin and somatostatin were infused to hold insulin-mediated glucose uptake constant between the two clamp studies. Skeletal muscle GLUT4 levels were assessed in EXO and control patients with Western blotting. Three patterns of peripheral and hepatic insulin sensitivity were seen that were related to the degree of pancreatic β-cell dysfunction. NEXO individuals had normal peripheral and hepatic insulin sensitivity. EXO individuals had enhanced peripheral insulin sensitivity that was not associated with a change in skeletal muscle glucose transporter abundance compared with control patients; paradoxically, EXO subjects demonstrated hepatic insulin resistance. EXO-IT had peripheral and hepatic insulin resistance. GMGU was diminished in both EXO and EXO-IT subjects. The unique combination of increased hepatic glucose production and increased peripheral glucose utilization seen in EXO may be a metabolic adaptation to increased peripheral energy needs. Increased glucose utilization is not attributable to a change in skeletal muscle GLUT4 or glycogen levels. Insulin resistance in CF patients with overt diabetes may be related to severe hyperglycemia secondary to impairment of insulin secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.43.8.1020

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 144

Metadata

Authors
Moran, A., Pyzdrowski, K. L., Weinreb, J., Kahn, B. B., Smith, S. A., Adams, K. S., & Seaquist, E. R.
Venue
Diabetes
Published
1994-08-01
Volume
43
Issue
8
Pages
1020-1026
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2132438678
Cited by
144
References
0
FWCI
2.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin Sensitivity in Cystic Fibrosis. https://app.cochat.ai/papers/10.2337/diab.43.8.1020
The paper
Moran, A., Pyzdrowski, K. L., Weinreb, J., Kahn, B. B., Smith, S. A., Adams, K. S., & Seaquist, E. R. (1994). Insulin Sensitivity in Cystic Fibrosis. Diabetes. https://doi.org/10.2337/diab.43.8.1020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.